Aryankalayil et al., 2014 - Google Patents
Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cellsAryankalayil et al., 2014
View HTML- Document ID
- 8774321730936476897
- Author
- Aryankalayil M
- Makinde A
- Gameiro S
- Hodge J
- Rivera-Solis P
- Palayoor S
- Ahmed M
- Coleman C
- Publication year
- Publication venue
- Radiation research
External Links
Snippet
To understand the impact of clinically relevant radiation therapy (RT) on tumor immune gene expression and to utilize the changes that occur during treatment to improve cancer treatment outcome, we examined how immune response genes are modulated in prostate …
- 238000001959 radiotherapy 0 title abstract description 33
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aryankalayil et al. | Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells | |
| Bradley et al. | Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection | |
| Qin et al. | miRNA-124 in immune system and immune disorders | |
| Jenner et al. | Insights into host responses against pathogens from transcriptional profiling | |
| Stegemann-Koniszewski et al. | Alveolar type II epithelial cells contribute to the anti-influenza A virus response in the lung by integrating pathogen-and microenvironment-derived signals | |
| Goubau et al. | Transcriptional re‐programming of primary macrophages reveals distinct apoptotic and anti‐tumoral functions of IRF‐3 and IRF‐7 | |
| CN108753817A (en) | The enhanced cell for enhancing the method for the anti-cancer ability of cell and being obtained using this method | |
| Shin et al. | IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells | |
| Kropp et al. | Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state | |
| Vlachiotis et al. | Lambda interferons in immunity and autoimmunity | |
| Froechlich et al. | Integrity of the antiviral STING-mediated DNA sensing in tumor cells is required to sustain the immunotherapeutic efficacy of herpes simplex oncolytic virus | |
| Hooks et al. | IFN-β provides immuno-protection in the retina by inhibiting ICAM-1 and CXCL9 in retinal pigment epithelial cells | |
| Krupna-Gaylord et al. | Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36 | |
| Marco et al. | MicroRNAs in autoimmunity and hematological malignancies | |
| Trotter et al. | IL26, a noncanonical mediator of DNA inflammatory stimulation, promotes TNBC engraftment and progression in association with neutrophils | |
| Zhao et al. | Chitosan nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced protection against HBV | |
| Ren et al. | HCV‐induced miR146a controls SOCS 1/STAT 3 and cytokine expression in monocytes to promote regulatory T‐cell development | |
| Bi et al. | Reticuloendotheliosis virus inhibits the immune response acting on lymphocytes from peripheral blood of chicken | |
| Picarda et al. | Cytomegalovirus evades TRAIL-mediated innate lymphoid cell 1 defenses | |
| Yang et al. | VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8+ T cell killing in colorectal cancer | |
| Zhang et al. | Differential expression and correlation analysis of miRNA–mRNA profiles in swine testicular cells infected with porcine epidemic diarrhea virus | |
| Sehgal et al. | IFN-α-induced downregulation of miR-221 in dendritic cells: implications for HCV pathogenesis and treatment | |
| Al‐Rayahi et al. | Tumour cell conditioned medium reveals greater M2 skewing of macrophages in the absence of properdin | |
| Liang et al. | The CXCL10/CXCR3 axis promotes disease pathogenesis in mice upon CVA2 infection | |
| Nagai-Singer et al. | NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells |